^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
anti-CD138 CAR-T
i
Other names: anti-CD138 CAR-T
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Affiliated Hospital of Xuzhou Medical University
Drug class:
CD138-targeted CAR-T immunotherapy
Related drugs:
over1year
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma. (PubMed, Cytotherapy)
Our results showed that low-dose or short-time use of G-CSF was not associated with the incidence or severity of CRS or NEs, and G-CSF administration did not influence the antitumor activity of CAR T-cell therapy.
Retrospective data • Journal • CAR T-Cell Therapy
|
SDC1 (Syndecan 1)
|
anti-CD138 CAR-T
Share via
